Timothy E. Morris
Chief Financial Officer, Vivus.
Companies
- Aquestive Therapeutics, Inc.Board member Aug 17, 2022 to now1
- DBV TechnologiesBoard member Apr 2, 2021 to Aug 28, 20232
- HUMANIGEN, INCChief financial officer Sep 22, 2020 to Jul 29, 20223
- HUMANIGEN, INCChief operating officer Sep 22, 2020 to Jul 29, 20223
- Iovance BiotherapeuticsChief financial officer Aug 16, 2017 to Mar 6, 20194
- HUMANIGEN, INCBoard member Jul 11, 2016 to Mar 13, 20185
- AcelRx Pharmaceuticals (United States)Chief financial officer Apr 9, 2014 to Feb 9, 20176
- VivusChief financial officer Jan 31, 2006 to Sep 9, 20137
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
DBV Technologies DBVT12,000 shares8$108.6K at $9.05Aug 25, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 25, 2023Bought 12,000 shares at $1.52 of DBV Technologies8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARDBV Technologies, Board member
- 3
- 4
- 5SEC EDGARHUMANIGEN, INC, Board member
- 6
- 7SEC EDGARVivus, Chief financial officer
- 8